Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Waiting for AML news. I went back and read again the last press release and on the SAME subject, they said two DIFFERENT things???????
PR is dated May 13, 2022.
May being the 5th month is in the 2nd quarter. OK.

In one part of the MAY PR they say: "After completing enrollment of the first 20 patients in the Phase 2 AML trial last year, we anticipate reporting topline data from the active disease group in the main phase of the trial next quarter.”

OK, so, IF in May (the 2nd quarter) you say "next quarter", then "next" would mean the 3rd quarter.

BUT, then a bit later they say: "Enrollment of the first 20 patients of the main Phase 2 stage of the AML trial was completed in Q4 2021. Topline readout of Group 2 active disease is anticipated in Q2 2022."

SO, are we expecting AML trial data news in the 3rd quarter? or the 2nd quarter (which ends TODAY)?

WTF?

And in any case, this would be data for the "active" arm, which should by far be the least successful.
Does anyone know when we are supposed the get AML news from the "adjuvant" arm?